HIVE Stock 12 Month Analyst Forecast
Eps Overview
Growth Next 5yrs
N/A
Last Quarter
- $0.38
Past Year
- $0.61
Growth Past 5yrs
1.63%
Next Quarter
- $0.20
Estimate Next Year
- $5.49
Consensus Rating
Loading...
Consensus Price Target
Highest Price Target
$10.00
262.32% Upside
Mean Price Target
$7.71
179.2% Upside
Lowest Price Target
$3.00
8.7% Upside
Recent Analyst Ratings
Upgrades, Downgrades, New Coverage
Last Updated On Apr 27, 2026
Actual EPS vs Estimated EPS
HIVE Earnings Per Share (EPS) History
According to financial reports, HIVE (NYSE: HIVE) reported an actual EPS of $-0.38 for the quarter ending on Feb 12, 2026, compared to an estimated $-0.07, resulting in a 442.86% surprise. In the prior quarter (Nov 14, 2025), HIVE recorded an actual EPS of $-0.01 with a 0.00% surprise. See HIVE's full earnings history.
Earnings History
EPS Surprise Factor Analysis
HIVE has experienced notable EPS surprises, with the latest quarter ending Feb 12, 2026 showing a 442.86% beat. Previously, the quarter ending Nov 14, 2025 recorded a 0.00% beat. An EPS surprise factor indicates how much actual earnings deviate from analyst forecasts.
| Report Date | Actual | Forecast | Surprise Factor |
|---|---|---|---|
| Feb 12, 2026 | -0.38 | -0.07 | +442.86% |
| Nov 14, 2025 | -0.01 | -0.01 | 0 |
| Aug 14, 2025 | -0.06 | -0.08 | -25.00% |
| Jun 25, 2025 | -0.31 | -0.11 | +181.82% |
| Feb 11, 2025 | -0.06 | -0.11 | -45.45% |
| Nov 12, 2024 | -0.06 | -0.09 | -33.33% |
Frequently Asked Questions
Is HIVE stock getting favorable reviews from Wall Street analysts?
Brokerage firms have given HIVE stock an average recommendation of
Buy. 17 analysts have given their ratings
to HIVE out of which
2 analysts have given strong buy call,
14 analysts have given buy call,
1 analysts rate it hold,
0 analysts advocate strong sell call, and
0 analysts has given sell rating. The average target price of
$7.71 gives the stock implied upside
of roughly 179.2% over the next year or so.
What have analysts suggested for HIVE highest price target?
Analysts suggest HIVE's stock price would rise to a high of $10.00.
What is the lowest price target analysts expect for HIVE over the next year?
Within the next 12 months, analysts predict the HIVE stock price could move to $3.00.
What is the average target price for HIVE?
HIVE stock has an average analyst estimate of $7.71.
At its current price, how far is HIVE from its average target price?
HIVE shares are currently trading 179.2% above this price target.
What were HIVE’s actual earnings per share for the recent quarter?
Its quarterly earnings per share (EPS) came in at - $0.38 versus consensus estimates of - $0.07, and below the comparable year-ago quarter’s EPS of - $0.06.
What are the current estimates for quarterly and annual earnings per share?
HIVE's forecasts by analysts estimating quarterly EPS at - $0.20 and - $5.49 for the whole year.
What has HIVE's growth been in the past five years and what is expected in the next five years?
The analysts have projected N/A EPS growth for HIVE in the next five years, compared to growth rates of 1.63% in the past five years.